The lectin pathway of complement activation contributes to protection from West Nile virus infection

Virology

Volumn 412, Issue 1, 2011, Pages 101-109

  Fuchs, Anja ^a   Pinto, Amelia K ^a   Schwaeble, Wilhelm J ^b   Diamond, Michael S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Complement; Flavivirus; Immunity; Lectin pathway; Pathogenesis

Indexed keywords

MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEASE 2; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN A; MANNOSE BINDING LECTIN C; PROTEIN MASP 2; PROTEIN MBL A; PROTEIN MBL C; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; DISEASE SEVERITY; FLAVIVIRUS INFECTION; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEST NILE FLAVIVIRUS; WILD TYPE;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; COMPLEMENT ACTIVATION; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES; WEST NILE FEVER; WEST NILE VIRUS;

FLAVIVIRUS; MUS; WEST NILE VIRUS;

EID: 79952535868     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.01.003     Document Type: Article

References (54)

1. Ahearn J.M., Fischer M.B., Croix D., Goerg S., Ma M., Xia J., Zhou X., Howard R.G., Rothstein T.L., Carroll M.C. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 1996, 4(3):251-262.
2. Bathum L., Hansen H., Teisner B., Koch C., Garred P., Rasmussen K., Wang P. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol. Immunol. 2006, 43(5):473-479.
3. Beasley D.W., Whiteman M.C., Zhang S., Huang C.Y., Schneider B.S., Smith D.R., Gromowski G.D., Higgs S., Kinney R.M., Barrett A.D. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J. Virol. 2005, 79(13):8339-8347.
4. Brien J.D., Austin S.K., Sukupolvi-Petty S., O'Brien K.M., Johnson S., Fremont D.H., Diamond M.S. Genotype specific neutralization and protection by antibodies against dengue virus type 3. J. Virol. 2010, 84:10630-10643.
5. Brien J.D., Uhrlaub J.L., Nikolich-Zugich J. Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur. J. Immunol. 2007, 37(7):1855-1863.
6. Brien J.D., Uhrlaub J.L., Nikolich-Zugich J. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J. Immunol. 2008, 181(12):8568-8575.
7. Brown A.N., Kent K.A., Bennett C.J., Bernard K.A. Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates. Virology 2007, 368(2):422-430.
8. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 2004, 5(10):981-986.
9. Carter T., Sumiya M., Reilly K., Ahmed R., Sobieszczuk P., Summerfield J.A., Lawrence R.A. Mannose-binding lectin A-deficient mice have abrogated antigen-specific IgM responses and increased susceptibility to a nematode infection. J. Immunol. 2007, 178(8):5116-5123.
10. Chong W.P., To Y.F., Ip W.K., Yuen M.F., Poon T.P., Wong W.H., Lai C.L., Lau Y.L. Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology 2005, 42(5):1037-1045.
11. Daffis S., Samuel M.A., Suthar M.S., Keller B.C., Gale M., Diamond M.S. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J. Virol. 2008, 82(17):8465-8475.
12. Diamond M.S. Progress on the development of therapeutics against West Nile virus. Antiviral Res. 2009, 83(3):214-227.
13. Diamond M.S., Mehlhop E., Oliphant T., Samuel M.A. The host immunologic response to West Nile encephalitis virus. Front. Biosci. 2009, 14:3024-3034.
14. Diamond M.S., Shrestha B., Marri A., Mahan D., Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 2003, 77:2578-2586.
15. Fuchs A., Lin T.Y., Beasley D.W., Stover C.M., Schwaeble W.J., Pierson T.C., Diamond M.S. Direct complement restriction of flavivirus infection requires glycan recognition by mannose binding lectin. Cell Host Microbe 2010, 8:186-195.
16. Gadjeva M., Paludan S.R., Thiel S., Slavov V., Ruseva M., Eriksson K., Lowhagen G.B., Shi L., Takahashi K., Ezekowitz A., Jensenius J.C. Mannan-binding lectin modulates the response to HSV-2 infection. Clin. Exp. Immunol. 2004, 138(2):304-311.
17. Gal P., Dobo J., Zavodszky P., Sim R.B. Early complement proteases: C1r, C1s and MASPs. A structural insight into activation and functions. Mol. Immunol. 2009, 46(14):2745-2752.
18. Garlatti V., Martin L., Lacroix M., Gout E., Arlaud G.J., Thielens N.M., Gaboriaud C. Structural insights into the recognition properties of human ficolins. J. Innate. Immun. 2009, 2(1):17-23.
19. Glass W.G., Lim J.K., Cholera R., Pletnev A.G., Gao J.L., Murphy P.M. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005, 202(8):1087-1098.
20. Gout E., Garlatti V., Smith D.F., Lacroix M., Dumestre-Perard C., Lunardi T., Martin L., Cesbron J.Y., Arlaud G.J., Gaboriaud C., Thielens N.M. Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. J. Biol. Chem. 2010, 285(9):6612-6622.
21. Guttormsen H.K., Stuart L.M., Shi L., Carroll M.C., Chen J., Kasper D.L., Ezekowitz R.A., Takahashi K. Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination. Clin. Immunol. 2009, 130(3):264-271.
22. Hacker K., White L., de Silva A.M. N-linked glycans on dengue viruses grown in mammalian and insect cells. J. Gen. Virol. 2009, 90(Pt 9):2097-2106.
23. Held K., Thiel S., Loos M., Petry F. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans. Mol. Immunol. 2008, 45(15):3934-3941.
24. Ip W.K., Takahashi K., Ezekowitz R.A., Stuart L.M. Mannose-binding lectin and innate immunity. Immunol. Rev. 2009, 230(1):9-21.
25. Ip W.K., Takahashi K., Moore K.J., Stuart L.M., Ezekowitz R.A. Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. J. Exp. Med. 2008, 205(1):169-181.
26. Johnson A.J., Roehrig J.T. New mouse model for dengue virus vaccine testing. J. Virol. 1999, 73(1):783-786.
27. Klein R.S., Lin E., Zhang B., Luster A.D., Tollett J., Samuel M.A., Engle M., Diamond M.S. Neuronal CXCL10 directs CD8+ T cell recruitment and control of West Nile virus encephalitis. J. Virol. 2005, 79(17):11457-11466.
28. Kopf M., Abel B., Gallimore A., Carroll M., Bachmann M.F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 2002, 8(4):373-378.
29. Krarup A., Mitchell D.A., Sim R.B. Recognition of acetylated oligosaccharides by human L-ficolin. Immunol. Lett. 2008, 118(2):152-156.
30. Lawrence R.A., Carter T., Bell L.V., Else K.J., Summerfield J., Bickle Q. Altered antibody responses in mannose-binding lectin-A deficient mice do not affect Trichuris muris or Schistosoma mansoni infections. Parasite Immunol. 2009, 31(2):104-109.
31. Mackenzie J.S., Gubler D.J., Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 2004, 10(12 Suppl):S98-S109.
32. Marsh J.E., Farmer C.K., Jurcevic S., Wang Y., Carroll M.C., Sacks S.H. The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation 2001, 72(7):1310-1318.
33. Mehlhop E., Diamond M.S. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 2006, 203(5):1371-1381.
34. Mehlhop E., Whitby K., Oliphant T., Marri A., Engle M., Diamond M.S. Complement activation is required for the induction of a protective antibody response against West Nile virus infection. J. Virol. 2005, 79:7466-7477.
35. Moller-Kristensen M., Ip W.K., Shi L., Gowda L.D., Hamblin M.R., Thiel S., Jensenius J.C., Ezekowitz R.A., Takahashi K. Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa. J. Immunol. 2006, 176(3):1769-1775.
36. Muller S., Schaffer T., Flogerzi B., Seibold-Schmid B., Schnider J., Takahashi K., Darfeuille-Michaud A., Vazeille E., Schoepfer A.M., Seibold F. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens. Gut 2010, 59(11):1493-1500.
37. Oliphant T., Engle M., Nybakken G., Doane C., Johnson S., Huang L., Gorlatov S., Mehlhop E., Marri A., Chung K.M., Ebel G.D., Kramer L.D., Fremont D.H., Diamond M.S. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 2005, 11(5):522-530.
38. Oliphant T., Nybakken G.E., Austin S.K., Xu Q., Bramson J., Loeb M., Throsby M., Fremont D.H., Pierson T.C., Diamond M.S. The induction of epitope-specific neutralizing antibodies against West Nile virus. J. Virol. 2007, 81:11828-11839.
39. Pedersen E.D., Loberg E.M., Vege E., Daha M.R., Maehlen J., Mollnes T.E. In situ deposition of complement in human acute brain ischaemia. Scand. J. Immunol. 2009, 69(6):555-562.
40. Petersen L.R., Marfin A.A., Gubler D.J. West Nile virus. Jama 2003, 290(4):524-528.
41. Purtha W.E., Myers N., Mitaksov V., Sitati E., Connolly J., Fremont D.H., Hansen T.H., Diamond M.S. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur. J. Immunol. 2007, 37:1845-1854.
42. Ruseva M., Kolev M., Dagnaes-Hansen F., Hansen S.B., Takahashi K., Ezekowitz A., Thiel S., Jensenius J.C., Gadjeva M. Mannan-binding lectin deficiency modulates the humoral immune response dependent on the genetic environment. Immunology 2009, 127(2):279-288.
43. Samuel M.A., Diamond M.S. Type I IFN protects against lethal West Nile Virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 2005, 79:13350-13361.
44. Samuel M.A., Diamond M.S. Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 2006, 80(19):9349-9360.
45. Samuel M.A., Whitby K., Keller B.C., Marri A., Barchet W., Williams B.R.G., Silverman R.H., Gale M., Diamond M.S. PKR and RNAse L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 2006, 80(14):7009-7019.
46. Sasaki K., Tsutsumi A., Wakamiya N., Ohtani K., Suzuki Y., Watanabe Y., Nakayama N., Koike T. Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand. J. Gastroenterol. 2000, 35(9):960-965.
47. Seppanen M., Lokki M.L., Lappalainen M., Hiltunen-Back E., Rovio A.T., Kares S., Hurme M., Aittoniemi J. Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection. Hum. Immunol. 2009, 70(4):218-221.
48. Shi L., Takahashi K., Dundee J., Shahroor-Karni S., Thiel S., Jensenius J.C., Gad F., Hamblin M.R., Sastry K.N., Ezekowitz R.A. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J. Exp. Med. 2004, 199(10):1379-1390.
49. Shresta S., Kyle J.L., Snider H.M., Basavapatna M., Beatty P.R., Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J. Virol. 2004, 78(6):2701-2710.
50. Szretter K.J., Samuel M.A., Gilfillan S., Fuchs A., Colonna M., Diamond M.S. The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J. Virol. 2009, 83(18):9329-9338.
51. Takahashi K., Ip W.E., Michelow I.C., Ezekowitz R.A. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr. Opin. Immunol. 2006, 18(1):16-23.
52. Takahashi M., Mori S., Shigeta S., Fujita T. Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway. Adv. Exp. Med. Biol. 2007, 598:93-104.
53. Tan Y., Liu L., Luo P., Wang A., Jia T., Shen X., Wang M., Zhang S. Association between mannose-binding lectin and HIV infection and progression in a Chinese population. Mol. Immunol. 2009, 47:632-638.
54. Thiel S., Frederiksen P.D., Jensenius J.C. Clinical manifestations of mannan-binding lectin deficiency. Mol. Immunol. 2006, 43(1-2):86-96.